PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
+3.9%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$328M
AUM Growth
+$328M
(+15%)
Cap. Flow
+$30.9M
Cap. Flow
% of AUM
9.43%
Top 10 Holdings %
Top 10 Hldgs %
45.79%
Holding
116
New
20
Increased
20
Reduced
14
Closed
21
Top Buys
| 1 |
Smith & Nephew
SNN
|
$10.9M |
| 2 |
STAAR Surgical
STAA
|
$7.16M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$6.26M |
| 4 |
Zimmer Biomet
ZBH
|
$5.89M |
| 5 |
Bruker
BRKR
|
$5M |
Top Sells
| 1 |
Dentsply Sirona
XRAY
|
$10.4M |
| 2 |
Axogen
AXGN
|
$6.79M |
| 3 |
Axsome Therapeutics
AXSM
|
$5.3M |
| 4 |
CELG
Celgene Corp
CELG
|
$4.72M |
| 5 |
Globus Medical
GMED
|
$3.95M |
Sector Composition
| 1 | Healthcare | 89.84% |
| 2 | Industrials | 2.49% |
| 3 | Consumer Staples | 1.36% |
| 4 | Materials | 0.27% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Novavax
NVAX
$1.2B
| – | – |
0
| – | – |
|
102
Omnicell
OMCL
$1.51B
| – | – |
0
| – | – |
|
103
Puma Biotechnology
PBYI
$258M
| – | – |
0
| – | – |
|
104
VanEck Pharmaceutical ETF
PPH
$625M
| – | – |
0
| – | – |
|
105
PTC Therapeutics
PTCT
$4.41B
| – | – |
-84,338
| Closed | -$3.17M |
|
106
Qiagen
QGEN
$10.1B
| – | – |
0
| – | – |
|
107
uniQure
QURE
$954M
| – | – |
-7,370
| Closed | -$440K |
|
|
SAGE
108
DELISTED
Sage Therapeutics
SAGE
| – | – |
-10,000
| Closed | -$1.59M |
|
109
SPDR S&P 500 ETF Trust
SPY
$656B
| – | – |
0
| – | – |
|
110
Stryker
SYK
$149B
| – | – |
0
| – | – |
|
111
Teladoc Health
TDOC
$1.37B
| – | – |
-57,500
| Closed | -$3.2M |
|
112
UnitedHealth
UNH
$279B
| – | – |
0
| – | – |
|
113
SPDR S&P Biotech ETF
XBI
$5.29B
| – | – |
0
| – | – |
|
114
Health Care Select Sector SPDR Fund
XLV
$33.8B
| – | – |
0
| – | – |
|
|
115
Dentsply Sirona
XRAY
$2.77B
| – | – |
-210,000
| Closed | -$10.4M |
|
|
ITCI
116
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| – | – |
-100,000
| Closed | -$1.22M |
|